The Department of Health and Human Services today delayed until July 1, 2019 implementation of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers.
Food and Drug Administration Commissioner Scott Gottlieb, M.D., yesterday shared an update on the agency’s work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities.
Ninety-one percent of all clinicians eligible for the Merit-based Incentive Payment System participated in the first year of the Quality Payment Program.
The Food and Drug Administration this week issued a safety communication reminding health care professionals of factors that increase the risk of surgical fires on or near a patient and offering recommendations to reduce these fires from occurring.
We believe it’s important for hospital and health system leaders to understand the trends and forces impacting the field, as well as the opportunities disruptive innovation may create. That’s why we’ve created a new home on AHA.org to track and analyze these trends.
The Food and Drug Administration yesterday provided an update on federal preparedness and the agency’s response efforts to the Ebola outbreak in the Democratic Republic of Congo.
The Substance Abuse and Mental Health Services Administration is accepting applications for $196 million to treat opioid use disorders through one of its grant programs.
The Food and Drug Administration today released two draft guidance documents aimed at reducing the ability of brand drug makers to use the agency’s Risk Evaluation and Mitigation Strategy programs as a way to block timely generic drug entry.
Virginia legislators yesterday voted to approve a budget bill that would expand access to Medicaid coverage to as many as 400,000 low-income residents.
The Missouri Hospital Association will receive the 2018 Dick Davidson Quality Milestone Award for Allied Association Leadership for its work to improve health care quality, AHA announced today.
The Centers for Medicare & Medicaid Services yesterday issued a notice detailing proposed changes to a claim-review demonstration project for Medicare fee-for-service home health services.
Standard & Poor’s Global Ratings last week said it believes that recent payment cuts to not-for-profit hospitals under the 340B drug savings program “will likely weaken their operating performance at a time of already tightening margins.”
A new AHA issue brief offers a prototype practice model to help hospitals and health systems meet the complex needs of older adults across care settings.
The module will allow Medicare plans to request that their payment arrangements receive “an other payer advanced APM determination” as part of the Quality Payment Program mandated by the Medicare Access and CHIP Reauthorization Act.
The Centers for Disease Control and Prevention today provided an update on the Ebola outbreak in the Democratic Republic of Congo and advised health care providers in the U.S. to continue to obtain a travel history from all patients seeking care.
The Bipartisan Budget Act retroactively extended the enhanced low-volume payment adjustment, which provides an add-on payment to qualifying low-volume hospitals to help improve access to care in rural areas.
More than 200 people in nine states have reported bleeding or other symptoms associated with exposure to synthetic cannabinoid products containing an anticoagulant agent, including five who died.